Yüklüyor......
Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm
In response to the coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), global efforts are focused on the development of new therapeutic interventions. For the treatment of COVID-19, selective lung-localizing strategies hold tremendous po...
Kaydedildi:
| Yayımlandı: | Nano Today |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Author(s). Published by Elsevier Ltd.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8026257/ https://ncbi.nlm.nih.gov/pubmed/33846686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nantod.2021.101149 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|